Furthermore, anti-CXCR3 antibody levels predict the deterioration of lung function in systemic sclerosis patients [35], while anti-CXCR3 antibodies predict cardiovascular risk in patients with cardiovascular diseases [36]. The gene discussed is CXCR3; the disease is cardiovascular disorder.